N-acetyl-L-leucine in Neurological Disorders: Mechanisms, Evidence, and Therapeutic Perspectives.
- 2026-04-28
- Cerebellum (London, England) 25(3)
- PubMed: 42047969
- DOI: 10.1007/s12311-026-01996-2
Study Design
- Type
- Review
No abstract available
Keywords: N-acetyl-L-leucine; Ataxia Telangiectasia; GM2-Gangliosidoses; Multiple sclerosis; Niemann-pick disease type C; Parkinson’s disease.
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|